SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-075932
Filing Date
2024-03-25
Accepted
2024-03-25 07:39:54
Documents
19
Period of Report
2024-03-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d93072d8k.htm   iXBRL 8-K 41359
2 EX-10.1 d93072dex101.htm EX-10.1 79061
3 EX-10.3 d93072dex103.htm EX-10.3 81947
4 EX-10.4 d93072dex104.htm EX-10.4 38700
5 EX-10.5 d93072dex105.htm EX-10.5 60834
9 GRAPHIC g93072g0322194520636.jpg GRAPHIC 5394
10 GRAPHIC g93072gdsp19.jpg GRAPHIC 8365
  Complete submission text file 0001193125-24-075932.txt   529086

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA dyn-20240321.xsd EX-101.SCH 2848
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyn-20240321_lab.xml EX-101.LAB 17979
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyn-20240321_pre.xml EX-101.PRE 11258
22 EXTRACTED XBRL INSTANCE DOCUMENT d93072d8k_htm.xml XML 3627
Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39509 | Film No.: 24776902
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)